Both atherosclerosis and arterial interventions induce oxidative stress mediated in part by nicotinamide adenine dinucleotide phosphate (NADPH) oxidases that have a pivotal role in the development of neointimal hyperplasia and restenosis. For small interfering RNA (siRNA) targeting of the NOX2 (Cybb) component of the NADPH oxidase to prevent restenosis, gene transfer with viral vectors is effective, but raises safety issues in humans. We developed a new approach using the amino-acid-based nanoparticle HB-OLD7 for local delivery of siRNA targeting NOX2 to the arterial wall. siRNA-nanoparticle complexes were transferred into the regional carotid artery walls after angioplasty in an atherosclerotic rat model. Compared with angioplasty controls, Cybb gene expression (measured by quantitative reverse transcriptase-PCR) in the experimental arterial wall 2 weeks after siRNA was reduced by 487%. The neointimato-media-area ratio was decreased by 483%, and the lumento-whole-artery area ratio was increased by 489%. Vital organs showed no abnormalities and splenic Cybb gene expression showed no detectable change. Thus, local arterial wall gene transfer with HB-OLD7 nanoparticles provides an effective, nonviral system for efficient and safe local gene transfer in a clinically applicable approach to knock down an NADPH oxidase gene. Local arterial knockdown of the Cybb gene significantly inhibited neointimal hyperplasia and preserved the vessel lumen without systemic toxicity.
Introduction
Atherosclerotic cardiovascular disease is a major cause of death and disability worldwide. Therapeutic interventions such as arterial angioplasty, stenting and bypass have shown great short-term success, but long-term success is still limited by restenosis induced by neointimal hyperplasia and arterial remodeling. Drugeluting stents have been proven to reduce restenosis in selected populations compared with bare-metal stents in relatively short-term studies. [1] [2] [3] However, concerns about drug-eluting stents have developed over longer periods of follow-up, including altered vascular healing with incomplete vessel wall and stent reendothelialization, late thrombus formation, restenosis and occurrence of myocardial infarction and death. [4] [5] [6] [7] [8] Recent systematic reviews, large-scale registry studies and a meta-analysis of 38 trials (18 023 patients) with a follow-up to 4 years, showed similar rates of overall mortality and myocardial infarction rates for patients treated with either drug-eluting or bare-metal stents. 9 Reactive oxygen species (ROS) activate cell proliferation and are functionally involved in the development of arterial stenosis after balloon angioplasty. During inflammation, these molecules are generated by the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a multicomponent membrane-bound enzyme complex that includes, as a functionally critical component, the CYBB gene product gp91-phox, also termed 'NOX2'. The NOX family includes NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1 and DUOX2. All NOX enzymes generate ROS, including oxygen radicals (such as superoxide, O 2 À ) and nonradicals (such as hydrogen peroxide, H 2 O 2 ) that are involved not only in cellular damage and killing of pathogens but also in a large number of reversible regulatory processes in virtually all cells and tissues. [10] [11] [12] [13] In the vascular wall, superoxide anion mediates oxidative damage in atherosclerosis, and macrophage NOX2 seems to be the major oxidase affecting intimal smooth muscle cells (SMCs).
14 NADPH oxidase also has a potent role in enhancing intima-media thickness in children with hypercholesterolemia. 15 NADPH oxidase deficiency significantly reduces atherosclerosis in apoE knockout mice, and atherosclerosis can be attenuated by limiting superoxide generation in both macrophages and vessel wall cells. 16 We found, by microarray analysis, that Cybb (NOX2) and Dpt (encoding the extracellular matrix protein dermatopontin) were the genes most upregulated by inflammation in the neointima at 4, 7 and 14 days after balloon angioplasty. 17 Inhibition of the NADPH oxidase with neutralizing antibody or peptide has been shown to decrease neointimal formation after arterial injury. 18, 19 Therapeutic knockdown of gene expression has been achieved by RNAi (RNA inhibition) from constructs expressed from viral vectors. For example, virus-mediated transfer of genes or small interfering RNA (siRNA) for inhibition of neointimal hyperplasia in rats or rabbits has been reported, using replication-defective adenovirusmediated knockdown of forkhead transcription factor genes to inhibit cell growth and cell-cycle progression, 20 complexed atelocollagen with siRNA targeting a heparinbinding growth factor Midkine 21 and lentiviral delivery of siRNA targeting an extracellular matrix-associated protein CCN1. 22 Viral transfer is effective, but also raises safety issues in humans, including insertional mutagenesis leading to malignancy. 23 To address these limitations, we developed a new approach using nonviral nanoparticles (a lysine based nanoparticle HB-OLD7) locally delivering siRNA. We hypothesized that nanoparticle delivery of siRNA to knock down NOX2 expression in the carotid artery wall after balloon angioplasty would prevent neointimal hyperplasia in a rat model of hypercholesterolemiainduced atherosclerosis.
Results
Nanoparticle-mediated siRNA transfer in vitro Figure 1 shows siGLO (siGLO-Dy 547) transfected into the SMC cytoplasma with the HB-OLD7 vector as red dots around the cell nucleus at 1, 2, 6 and 18 days, as detected by longitudinal spinning disk confocal microscopy. siGLO was transfected into all the cells after 24 h, and carried into the daughter cells, as seen in the day-18 image.
Mouse experiments
After 1, 3 and 4 days tail vein injection of siGLO and HB-OLD7 complex, the mice were scanned under a Xenogen IVIS100 imaging system. Organ cryosection slide images (Supplementary Figure 1) showed that siGLO (red dots) were seen in the vital organs (such as the liver, spleen, kidney, lung, heart and brain) and leg and thigh muscles. No evidence of transfection was found in the carotid artery cross-sections (image not shown). The percentages of siGLO-positive organ cells, quantified using MetaMorph software, version 7.6.3., are presented in Table 1 .
Images of fluorescent staining for NOX2 in isolated mouse spleen phagocytes 3 days after tail vein injection of nanoparticles alone or nanoparticle-siCybb complex are shown in Supplementary Figure 2 . NOX2 was expressed in 12.65% of spleen phagocytes in mice treated with the empty nanoparticle control, compared with 9.91% in mice receiving nanoparticle-siCybb complex, a 27.4% decrease.
The mouse spleen cryoslides were also double immunostained for NOX2 and the phagocyte marker CD11b (Supplementary Figure 3) . Quantification of 10 images of each group using IMAGE-PRO PLUS 6.2 software (Media Cybernetics, Inc., Bethesda, MD, USA) showed that the proportion of NOX2-positive phagocytes in the nanoparticle-siCybb complex-treated mice decreased by 60% compared with the empty nanoparticle group.
Western blots of protein expression in three mice spleens are shown in Supplementary Figure 4 . NOX2 expression in the spleen after intravenous administration Figure 1 siGLO-nanoparticle complex transfection in rat thoracic aorta SMC in culture. Spinning disk fluorescent confocal microscopy at days 1-18 after transfection shows intracellular siRNA-Dy547 (siGLO, red dots). Scale bar: Â 20 50 mm; Â 60 25 mm. 
Atherosclerotic rat model
Hematoxylin and eosin staining showed calcium deposits in the ascending thoracic aorta after 6 weeks and atherosclerotic plaques formed in the aortas after 10-12 weeks (Figure 2 ) of the high-fat diet. Hence, we conducted rat experiments 10-12 weeks after the initiation of the diet. Compared with pre-high-fat diet, blood cholesterol, triglycerides and low-density lipoprotein levels were increased after 6 weeks of high-fat chow (Po0.001). There were no significant changes in highdensity lipoprotein or very-low-density lipoprotein. Liver functions (aspartate transaminase and alanine transaminase) and kidney function (creatinine) did not show significant changes after high-fat chow. Blood granulocytes, monocytes and lymphocytes were increased at 2 weeks after surgery, probably in response to surgical injury, with no significant effect between control and experimental groups.
Effects of nanoparticle-siSTABLE-Cybb complex transfer
To experiment the feasibility of using nanoparticles to deliver siRNA into the local arterial wall, we test the route of transferring the HB-OLD7 and siGLO complex (red fluorescence) to the carotid artery by luminal and adventitial approaches after balloon angioplasty. Four days after delivery by the local adventitia approach, siGLO (red dots) was detectable throughout the arterial wall by fluorescent microscopy with suppression of autofluorescence ( Figure 3a ) and by high-resolution fluorescent confocal microscopy ( Figure 3b ). We tested an alternative approach through the regional vessel lumen by introducing the nanoparticle-siGLO complex into the arterial lumen after balloon angioplasty, with the blood circulation interrupted for 25 min using nontraumatic micro-vascular clamps. After 4 days, there was no evidence of siGLO-Dy547 into the arterial wall (images not shown). Therefore, the peri-adventitial route of siRNA transfer was used in further studies.
The nanoparticle HB-OLD7-siSTABLE-Cybb (siCybb) complex was delivered to the adventitia of the left carotid artery after balloon angioplasty in the atherosclerotic rat model. The bilateral carotid arteries and spleen were removed 2 weeks later and analyzed by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) and western blot to evaluate the effectiveness of siRNA knockdown of NOX2. In addition, the functional consequences of NOX2 knockdown were analyzed by histological morphometric analysis of intimal-to-media-area ratio and luminal-towhole-artery area ratio.
mRNA expression. qRT-PCR was performed to measure mRNA expression in the rat carotid artery and the spleen. Levels of target gene (Cybb) expression were normalized over the internal control gene rps6 (ribosomal protein s6). As shown in Figure 4a , in the carotid artery, nanoparticle delivery of siCybb reduced Cybb expression by 87.1, 87.3 and 88.6% relative to angioplasty only, vector control and siControl (a nontargeting siRNA control, which targets luciferase) groups, respectively (n ¼ 6). No systemic change in Cybb expression was observed in the spleen after local transfer of siCybb in the carotid artery (Figure 4b ).
There were no changes in the levels of NOX4 mRNA expression in the rat carotid artery after angioplasty with and without siCybb-nanoparticle complex transfer, as shown in Supplementary Figure 5 .
Protein expression. Immunoblots were probed with antibodies to NOX2 and CD11b (phagocytes marker), detected by chemiluminescence. As shown in Figure 5a , NOX2 protein expression in the carotid artery, standardized to CD11b and to a-tubulin proteins after nanoparticle-mediated siCybb transfer, was decreased by 71.9, 73.1 and 70.2% relative to angioplasty only, empty nanoparticle and siControl groups (n ¼ 5), respectively. Normalization to CD11b was used to control for differing numbers of phagocytes in the samples. In the spleen, no significant differences were observed between the groups in NOX2 protein levels ( Figure 5b ).
ROS production. Figure 6 presents cryosections of the rat carotid arteries stained with dihydroethidium, an indicator of superoxide anions, at 2 weeks after siRNA delivery. Superoxide (red stain) is evident in the thickened neointima and adventitia in the nanoparticle vector control artery. Notably, in the nanoparticle-siCybb complex-treated arteries, neointima formation was inhibited and very little superoxide was detectable in the arterial wall ( Figure 6 ). ROS expression was quantitated using the IMAGE-PRO PLUS 6.2 software. After siCybb transfer, the proportion of ROS-positive arterial cells was decreased by 89.7 and 72.6%, compared with transfer of nanoparticles alone.
Neointima formation. Cryosections of the carotid arteries were stained with hematoxylin and eosin, and the areas of neointimal hyperplasia and vessel lumen were measured by digital imaging planimetry. As shown in Figure 7 , neointima formation was dramatically Figure 2 Cross-section of rat aortas after feeding high-fat chow. Hematoxylin and eosin staining shows calcium deposition in the ascending aorta after 6 weeks and atherosclerotic plaques were in the ascending and descending aortas after 10-12 weeks on the high-fat diet.
Local arterial nanoparticle delivery of siRNA-NOX2 JM Li et al inhibited, with intimal-to-media-area ratio decreased by 483%. Lumen areas were significantly preserved, with luminal-to-whole-artery area ratio increased by 489% compared with the angioplasty control group (n ¼ 6).
Discussion
Arterial injury in atherosclerotic arteries leads to the infiltration and activation of leukocytes, with induction of local ROS production, as well as cytokine and chemokine release, which accelerate the formation of neointimal hyperplasia. 24 Our laboratory has shown that inflammatory cells including monocytes and neutrophils adhere and infiltrate into the artery wall after angioplasty in the rat carotid artery, 17 nonatherosclerotic rabbit 25 and atherosclerotic rabbit models. 26 ROS are generated in vascular cells by NADPH oxidases, uncoupled endothelial nitric oxide synthase producing superoxide rather than nitric oxide and other enzymatic sources, or as byproducts of mitochondrial respiration. 27 The most active of these systems, the phagocyte NADPH oxidase, is a multicomponent membrane-bound enzyme complex that belongs to the NOX family. NOX2 is a ) and nonradicals, (such as hydrogen peroxide, H 2 O 2 ), that are either oxidizing agents or are easily converted into radicals. ROS are involved not only in cellular damage and killing of pathogens but also in a large number of reversible regulatory processes in virtually all cells and tissues. [10] [11] [12] [13] ROS have a critical role in vascular injury. In the vascular wall, superoxide anion mediates oxidative damage in atherosclerosis, and macrophage NOX2 appears to be the major oxidase affecting human intimal SMC. 14 In this study, siRNA targeting NOX2 was successfully transferred to the local arterial wall using a new nanoparticle vector, HB-OLD7, delivered by an adventitia approach at 2 weeks after angioplasty in atherosclerotic rats. Transfection of fluorescent-tagged siRNA by HB-OLD7 carrier into rat arterial SMC persisted in the original transfected cells and daughter cells for up to 18 days.
Nanoparticle delivery of siRNA to Cybb, the gene encoding NOX2, resulted in the inhibition of neointimal hyperplasia and preserved luminal area by B90% at 2 weeks after arterial intervention. Our previous studies have shown that neointimal hyperplasia reaches a plateau at 2-4 weeks after surgery in rat, 17 rabbit 25, 26 and pig models. 28 However, the accelerated development of hyperplasia in animals is in contrast to the usual time course for the development of neointimal hyperplasia in humans, which ranges from months to a year or more. Ongoing studies of the long-term effects of siRNA silencing are evaluating these measurements at times up to 18 months.
The absence of a similar effect from delivery of negative control construct indicates that the observed biochemical and histological changes resulted from NOX2 silencing, not from the alternative, nonspecific mechanism of Toll-like receptor 3 activation. 29, 30 Phagocyte ROS generated by NOX2 also provide beneficial microbicidal activity critical to host defense against bacteria and fungi. 31 In theory, systemic delivery of the nanoparticle siRNA-Cybb complex could silence Cybb expression and impair host defense against these organisms, as in the hereditary disorder chronic granulomatous disease. 32 However, clinically significant impairment of host defense does not occur unless ROS production in the rat carotid artery after angioplasty and siCybb-nanoparticle complex transfer. The carotid arteries were harvested 2 weeks after treatment and cryosections stained with dihydroethidium (DHE), an indicator of superoxide anions. Superoxide (red stain) is evident in the thickened neointima and adventitia in the nanoparticle control group (left panel). In the rat arteries treated with siCybb-nanoparticle complex (middle and right panels), neointima formation was significantly inhibited and very little superoxide is seen in the arterial wall. The far right panel graphically displays ROS in the arterial wall, quantified using IMAGE-PRO PLUS software and expressed as percentage relative to the nanoparticle-only control in two experiments. Scale bar: 100 mm.
Local arterial nanoparticle delivery of siRNA-NOX2 JM Li et al NOX2 activity decreases below 10% of normal: mutations leading to retention of 5-10% normal activity lead to clinically milder 'variant' chronic granulomatous disease, and carriers of X-linked chronic granulomatous disease are asymptomatic unless random X inactivation produces a distribution of 490% abnormal cells. 33 In our studies with systemic (intravenous) administration of the nanoparticle siRNA-Cybb complex in mouse, spleen phagocyte Cybb expression decreased by only 30%. Far less systemic distribution would be expected from local administration of the nanoparticles to the arterial adventitia. Indeed, as shown in Figures 5b and 6b , there were no detectable changes in phagocyte Cybb gene expression or NOX2 protein levels in splenic phagocytes.
Overall, the present studies show that siRNA delivered by the nanoparticle vector HB-OLD7 can be tranfected into arterial SMC in culture, and transferred into a blood vessel wall in vivo. Systemic and arterial luminal routes of administration did not effectively transfer siRNA into the arterial wall. However, a local arterial adventitial approach successfully transferred the siCybb-nanoparticle complex into the rat common carotid artery after angioplasty and significantly silenced regional Cybb gene expression, inhibited intimal hyperplasia and preserved the artery lumen area. Nanoparticlemediated local arterial delivery of siCybb resulted in no abnormal liver or kidney function or histology, nor in any changes in spleen histology, Cybb transcript levels or NOX2 protein expression. The siRNA-Cybb signaling pathway is under further investigation.
The peri-adventitia delivery approach would be clinically applicable in open vascular reconstructive surgery, such as coronary artery bypass or carotid artery endarterectomy, which remain common procedures for the treatment of coronary and carotid artery atherosclerotic stenosis. 34, 35 Delivery of siRNA to the adventitia is both practically convenient in open vascular surgery and pathophysiologically appropriate. 36 In recent years, evidence has emerged indicating that the vascular adventitia is activated early in various cardiovascular diseases and that NADPH oxidase-derived ROS from the adventitia have an important role in the initiation and progression of vascular inflammation, arterial remodeling and intimal hyperplasia.
Materials and methods
siRNA and nanoparticle formation siGLO-Dy547 is a nontargeting siRNA tagged with red fluorescence dye Dy547. siControl is a nontargeting siRNA control, which targets luciferase. siGLO-Dy547, siControl and siSTABLE-Cybb (siCybb) are stabilityenhanced siRNA for in vivo study constituted by Dharmacon RNAi Technologies (Lafayette, CO, USA), with average molecular weight of 13 300 g mol À1 . siSTABLE-Cybb, which targets CYBB (GenBank accession NM_023965), represents an siRNA pool designed with the 'inVIVO SMARTpool' technique (Dharmacon RNAi Technologies) that incorporates a multicomponent algorithm to identify siRNAs with a high probability of potent and specific silencing. SMARTpool reagents combine four SMART selection-designed siRNA into a single pool. The siRNAs were targeted to the Cybb open-reading frame, and follow a leader AA, but the AA dinucleotide is not in part of the 19-nt sequence core. The sequences of the siSTABLE-Cybb siRNAs are: ACGAUG AGCCUAAAUAUAA, GCAGGGACACGCAUGCUUU, GCUACAACAUCUACCUUAC and UCAAGACCAUU GCAAGUCA; these target Cybb sequences in exons 2, 11, 11 and 12, respectively.
HB-OLD7 nanoparticles were developed by Dr Tariq Rana's laboratory as described previously. The lysinebased nanoparticles feature surface modifications incorporating oleic acid, a monounsaturated omega-9 fatty acid, as a functional group, molecular weight 5798 g mol
À1
. Figure 7 Neointimal and luminal area of the rat carotid artery after angioplasty and siRNA-nanoparticle HB-OLD7 complex transfer. The carotid arteries were harvested 2 weeks after treatment and cryosections were stained with hematoxylin and eosin. Neointima formation was dramatically inhibited and the arterial lumen size remarkably preserved by treatment with the siCybb-HB-OLD7 complex, compared with angioplasty alone, nanoparticle control and siControl groups. (n ¼ 6) Bar graphs present quantitative measures of neointima to media (left panel) and lumen to whole artery (right panel) ratios. Scale bar: 100 mm.
Local arterial nanoparticle delivery of siRNA-NOX2 JM Li et al HB-OLD7 binds to siRNA through electrostatic interaction and forms nanoparticles with diameter o200 nm. The functionalized nanoparticle-siRNA complexes initiate contacts with the cell membrane for entry and intracellular release of the siRNA. 37, 38 Primers for rat and mouse Cybb, NOX4 and internal control rps6 oligonucleotides were obtained from Operon (Huntsville, AL, USA). Antibodies to NOX2 and CD11b were obtained from BD Biosciences (San Jose, CA, USA).
In vitro experiment
To determine the efficacy of siRNA transfection, siGLODy547 was used to transfect SMCs using HB-OLD7 as a vector. Rat descending thoracic aorta SMCs were explanted and passages 2-3 were seeded onto a 35 mm glass culture dishes (MatTek, Ashland, MA, USA) in Waymouths' MB752/1 medium plus L-glutamine (Invitrogen Corp., Grand Island, NY, USA). The final concentration of siGLO in 35 mm dish was 100 nmol l À1 with 1:1 siGLO to -HB-OLd7 weight ratio. The efficacy of transfection was monitored using a CSU10B Spinning Disk Confocal System (Solamere Technology Group, Salt Lake City, UT, USA) attached to a Nikon TE2000-E2 automated inverted microscope (Melville, NY, USA) at 1, 2, 6 and 18 days after transfection.
Mouse experiments
All animal experiments were conducted with the approval of the University of Massachusetts Medical School Institutional Animal Care and Use Committee.
To track siRNA biodistribution after intravenous administration, the siGLO-HB-OLD7complex was administrated by intravenous injection in wild-type C57BL/6J mice. The siGLO-Dy547 (1 mg kg À1 body weight) and HB-OLD7 complex (1:8 W/W ratio) 37 was injected through the tail vein. After 1, 3 and 4 days, the mice were scanned using a Xenogen IVIS100 imaging system (Caliper LifeSciences, Hopkinton, MA, USA), and then killed. The carotid arteries, vital organs and thigh muscles (vastus lateralis and biceps femoris) and leg muscle (gastrocnemius) were removed and cryosectioned. siGLO distribution in the organs was imaged by fluorescent microscopy (Olympus IX-70, Olympus America Inc., Center Valley, PA, USA) and quantified with MetaMorph software, version 7.6.3 (MDS Analytical Technologies, Dowingtown, PA, USA).
Spleen monocytes and macrophages (Mono/Macro) were harvested using BD Falcon Cell Strainer, 70 mm (BD Biosciences) and assayed for NOX2 expression 3 days after HB-OLD7 alone or siCybb-HB-OLD7 complex intravenous administration. Equal amount of cells were seeded into 8-chamber cover slide (Lab-Tek/Chamber Slide, Cat no. 177445, Nalge Nunc International, Rochester, NY, USA) for NOX2 immunostaining.
Rat experiments Atherosclerosis induction and arterial balloon injury. White Sprague-Dawley rats (male, 400±25 g body weight) were administered vitamin D 3 60 000 IU per 100 g body weight intraperitoneally, 39 and fed with a high-fat chow containing 21% fat and 0.15% cholesterol (Cat no. 5TKW, TestDiet Co., Richmond, IN, USA). The aortas were subsequently removed weekly after 3-12 weeks of feeding high-fat chow for histological evaluation of the atherosclerosis status. There was calcium deposition in the ascending aorta at 6 weeks, and obvious plaques in the inner layer of the ascending and descending aortas beginning at 10 weeks. On the basis of these longitudinal observations, the rats were allowed to maintain this diet up until 10-12 weeks at which point balloon angioplasty of the left common carotid artery was performed. The rats were fed regular chow after surgery.
Analgesics Depodur (liposome-encapsulated morphine) 2.8 mg kg
À1
, and glycopyrrolate 0.02 mg kg
, an anticholinergic drug used to maintain heart rate and decrease salivation, were administered subcutaneously before induction of anesthesia. General anesthesia was induced in a 5% isoflurane chamber, and maintained with 1-2% isoflurane inhalation through a cone mask. The left carotid artery was injured using a 2F arterial embolectomy catheter (Fogarty, Edwards Lifesciences, Irvine, CA, USA) introduced through the external carotid artery under temporary clamping of the proximal common carotid and internal carotid arteries. The balloon was inflated and withdrawn three times to expand the artery and denude endothelium. 17 The total volume of the nanoparticle-siRNA complex was 100 ml. The weight ratios of nanoparticle to siGLO (5.3 mg) were first tested from 20:1 to 200:1 for tracing siRNA-Dy547 (red) under fluorescent microscope at 4 days after transfer. Red dots were seen throughout the regional arterial wall at all ratios above 80:1. Hence, the nanoparticle:siRNA (93 mg) ratio of 100:1 was used in all subsequent experiments.
For the rat experiments, HB-OLD7 was encapsulated with siGLO, siControl or siCybb at 100:1 weight ratio at 22 1C for 20 min to 1 h before use. Nanoparticles or nanoparticles encapsulating with one of these siRNAs were applied circumferentially to the adventitia of the left carotid artery after balloon angioplasty.
Blood was drawn through the retro-orbital route before the high-fat diet, on the day of surgery, and at termination (2 weeks after surgery) for measurements of serum lipids, aspartate transaminase, alanine transaminase and creatinine. Blood cell numbers and distribution were also measured.
There were four animal groups in each trial: three control groups (angioplasty only, nanoparticle control and nanoparticle-siControl complexes) and a treatment group that received siCybb.
Fluorescent-labeled siRNA was detected in the arterial wall by fluorescent microscopy (Olympus IX) and highresolution fluorescent confocal microscopy Leica DM IRBE (Leica Microsystems Inc., Bannockburn, IL, USA). The images were later processed to remove autofluorescence using the Nuance FX multispectral imaging system (CRI Inc., Woburn, MA, USA) and Nuance software.
In vivo Cybb (NOX2) knockdown. Two weeks after angioplasty and treatment with empty nanoparticles or nanoparticles delivering siControl or siSTABLE-Cybb, bilateral carotid arteries and spleens were harvested into RNAlater (an RNA stabilization solution for tissue collection; Ambion, Austin, TX, USA) for later study. The specimens were evaluated for the molecular effects of NOX2 knockdown and for ROS production with immunofluorescent staining. Western immunoblot and qRT-PCR were used for quantification of NOX2, as well as for NOX4 (an arterial SMC oxidase).
Local arterial nanoparticle delivery of siRNA-NOX2 JM Li et al Quantitative RT-PCR was used to detect mRNA expression levels of NOX2 and NOX4 relative to the internal control gene rps6 in the rat carotid artery, and of NOX2 in the spleen. The samples were mechanically homogenized with POLYTRON PT 2100 (Kinematica Inc., subsidiary of Kinematica, AG (Lucerne, Switzerland), Bohemia, NY, USA). Total RNA was extracted with TRIzol (Invitrogen Corp.). First-strand cDNAs were synthesized with an anchored oligo(dT) primer using Superscript III first-strand synthesis Super MIX for qRT-PCR (Invitrogen Corp.). Real-time PCR was performed on a Realplex 2 Mastercycler epgradient S (Eppendorf North America, Westbury, NY, USA). The relative standard curve derived from serial dilutions of sample first-strand cDNA was used for quantification. Levels of target gene expression for rat samples were normalized over the internal control gene rps6.
Vascular SMCs express mRNA for NOX4, which shares B39% identity to NOX2. 13 To determine the specificity of the NOX2 knockdown, we also evaluated the expression of NOX4 mRNA in the same arterial specimens.
NOX2 protein knockdown was evaluated by immunofluorescent staining and western blot. Cryosections of the carotid arteries harvested at intervals after balloon angioplasty with and without siRNA treatment were doublestained with mouse monoclonal antibody to NOX2 and mouse anti-rat CD11b (BD Biosciences). Second antibodies used for NOX2 and CD11b were, respectively, fluorescein isothiocyanate-conjugated AffiniPure goat anti-mouse IgG (H+L) and Rhodamine Red-X-conjugated AffiniPure goat anti-mouse IgG (H+L) (Jackson ImmuResearch Laboratories Inc., West Grove, PA, USA).
For western blotting, samples were homogenized in Cell Lysis Buffer (Cell Signaling Technology Inc., Danvers, MA, USA) supplemented with Protease Inhibitor Cocktail (Sigma-Aldrich, St Louis, MO, USA). Sample proteins were separated on 10% precast polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA, USA) and then electrotransferred to nitrocellulose (0.45 mm) membrane (Bio-Rad Laboratories). The membranes were probed with each of the primary antibodies to NOX2 or CD11b (BD Biosciences). Signals were detected with Western Lighting Chemiluminescence Reagent Plus (Perkin-Elmer LAS Inc., Waltham, MA, USA). Protein band intensity was quantified using the ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Cryosections of the carotid artery samples were subjected to histochemical staining with dihydroethidium (Invitrogen Corp.), an indicator of superoxide anions.
Histomorphometry. For histomorphometric measurements, bilateral carotid artery samples were retrieved after in situ perfusion with 0.9% saline and fixation with 4% paraformaldehyde at 110-120 mm Hg pressure for 30 min. Samples were then kept in 4% paraformaldehyde for at least 48 h. The artery samples were then crosssectioned into proximal 1/3, middle1/3 and distal 1/3 segments and snap frozen with O.C.T. compound (Tissue-Tek, Sakuru Finetek USA, Inc., Torrance, CA, USA). The cryosections were processed to 5 mm thickness and 10 sections for each segment for hematoxylin and eosin staining. Neointimal and luminal areas were measured with digital imaging planimetry using ImageJ software.
Detection of systemic silencing effects. The spleens were retrieved along with the bilateral carotid arteries from each animal at termination and evaluated for NOX2 expression with: (1) double immunofluorescent staining for NOX2 and CD11b (phagocyte marker); (2) western blot for NOX2 and CD11b proteins; and (3) quantitative RT-PCR for Cybb mRNA expression, and immunohistofluorescent staining. The liver and kidney were also retrieved for histological evaluation.
Statistical analysis. The effects of treatment, and arterial segment were evaluated by ANOVA (analysis of variance) for mixed models. 40 In the presence of significant main or interaction effects, pairwise comparisons were performed using the Tukey-Kramer multiple comparisons procedure. 41 The distributional characteristics of the outcome variables were assessed using the Kolmogorov-Smirnov goodness-of-fit test for normality on model residuals. All computations were performed using SAS 9.1.3 Proc Mixed (SAS Institute Inc., Torrance, CA, USA) and SPSS 14 statistical software (SPSS Inc., Chicago, IL, USA). Po0.05 is considered significant.
